Your browser doesn't support javascript.
loading
Needlestack: an ultra-sensitive variant caller for multi-sample next generation sequencing data.
Delhomme, Tiffany M; Avogbe, Patrice H; Gabriel, Aurélie A G; Alcala, Nicolas; Leblay, Noemie; Voegele, Catherine; Vallée, Maxime; Chopard, Priscilia; Chabrier, Amélie; Abedi-Ardekani, Behnoush; Gaborieau, Valérie; Holcatova, Ivana; Janout, Vladimir; Foretová, Lenka; Milosavljevic, Sasa; Zaridze, David; Mukeriya, Anush; Brambilla, Elisabeth; Brennan, Paul; Scelo, Ghislaine; Fernandez-Cuesta, Lynnette; Byrnes, Graham; Calvez-Kelm, Florence L; McKay, James D; Foll, Matthieu.
Afiliación
  • Delhomme TM; Genetic Cancer Susceptibility Group, Section of Genetics, International Agency for Research on Cancer (IARC-WHO), 150 cours Albert Thomas, 69008 Lyon, France.
  • Avogbe PH; Genetic Cancer Susceptibility Group, Section of Genetics, International Agency for Research on Cancer (IARC-WHO), 150 cours Albert Thomas, 69008 Lyon, France.
  • Gabriel AAG; Genetic Cancer Susceptibility Group, Section of Genetics, International Agency for Research on Cancer (IARC-WHO), 150 cours Albert Thomas, 69008 Lyon, France.
  • Alcala N; Genetic Cancer Susceptibility Group, Section of Genetics, International Agency for Research on Cancer (IARC-WHO), 150 cours Albert Thomas, 69008 Lyon, France.
  • Leblay N; Genetic Cancer Susceptibility Group, Section of Genetics, International Agency for Research on Cancer (IARC-WHO), 150 cours Albert Thomas, 69008 Lyon, France.
  • Voegele C; Genetic Cancer Susceptibility Group, Section of Genetics, International Agency for Research on Cancer (IARC-WHO), 150 cours Albert Thomas, 69008 Lyon, France.
  • Vallée M; Genetic Epidemiology Group, Section of Genetics, International Agency for Research on Cancer (IARC-WHO), 150 cours Albert Thomas, 69008 Lyon, France.
  • Chopard P; Genetic Epidemiology Group, Section of Genetics, International Agency for Research on Cancer (IARC-WHO), 150 cours Albert Thomas, 69008 Lyon, France.
  • Chabrier A; Genetic Cancer Susceptibility Group, Section of Genetics, International Agency for Research on Cancer (IARC-WHO), 150 cours Albert Thomas, 69008 Lyon, France.
  • Abedi-Ardekani B; Genetic Cancer Susceptibility Group, Section of Genetics, International Agency for Research on Cancer (IARC-WHO), 150 cours Albert Thomas, 69008 Lyon, France.
  • Gaborieau V; Genetic Epidemiology Group, Section of Genetics, International Agency for Research on Cancer (IARC-WHO), 150 cours Albert Thomas, 69008 Lyon, France.
  • Holcatova I; Institute of Hygiene and Epidemiology, Charles University, 1st Faculty of Medicine, 116 36 Prague, Czech Republic.
  • Janout V; Faculty of Health Sciences, Palacky University, 775 15 Olomouc, Czech Republic.
  • Foretová L; Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, 656 53 Brno, Czech Republic.
  • Milosavljevic S; International Organization for Cancer Prevention and Research (IOCPR), 11070 Belgrade, Serbia.
  • Zaridze D; Russian N.N. Blokhin Cancer Research Centre, 115478 Moscow, The Russian Federation.
  • Mukeriya A; Russian N.N. Blokhin Cancer Research Centre, 115478 Moscow, The Russian Federation.
  • Brambilla E; Centre Hospitalier Universitaire de Grenoble Département d'Anatomie et Cytologie Pathologiques, CS 10217 38043 Grenoble, France.
  • Brennan P; Genetic Epidemiology Group, Section of Genetics, International Agency for Research on Cancer (IARC-WHO), 150 cours Albert Thomas, 69008 Lyon, France.
  • Scelo G; Genetic Epidemiology Group, Section of Genetics, International Agency for Research on Cancer (IARC-WHO), 150 cours Albert Thomas, 69008 Lyon, France.
  • Fernandez-Cuesta L; Genetic Cancer Susceptibility Group, Section of Genetics, International Agency for Research on Cancer (IARC-WHO), 150 cours Albert Thomas, 69008 Lyon, France.
  • Byrnes G; Section of Environment and Radiation, International Agency for Research on Cancer (IARC-WHO), 150 cours Albert Thomas, 69008 Lyon, France.
  • Calvez-Kelm FL; Genetic Cancer Susceptibility Group, Section of Genetics, International Agency for Research on Cancer (IARC-WHO), 150 cours Albert Thomas, 69008 Lyon, France.
  • McKay JD; Genetic Cancer Susceptibility Group, Section of Genetics, International Agency for Research on Cancer (IARC-WHO), 150 cours Albert Thomas, 69008 Lyon, France.
  • Foll M; Genetic Cancer Susceptibility Group, Section of Genetics, International Agency for Research on Cancer (IARC-WHO), 150 cours Albert Thomas, 69008 Lyon, France.
NAR Genom Bioinform ; 2(2): lqaa021, 2020 Jun.
Article en En | MEDLINE | ID: mdl-32363341
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Diagnostic_studies Idioma: En Año: 2020 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Diagnostic_studies Idioma: En Año: 2020 Tipo del documento: Article